Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 4 Multiple Pulmonary Nodules 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Solitary Pulmonary Nodule 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Recurrence 1 Melanoma 1 Lymphoma, Follicular 1 Lung Diseases 1 Inflammatory Bowel Diseases 1 Head and Neck Neoplasms 1 Glioma 1 Depressive Disorder, Major 1 Breast Neoplasms 1 Breast Neoplasm Female 1 Bone Neoplasms 1 Barrett Esophagus 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Cisplatin 150 Radiotherapy 121 Cetuximab 96 Docetaxel 60 Fluorouracil 56 Paclitaxel 45 Radiotherapy, Intensity-Modulated 41 Carboplatin 40 pembrolizumab 34 Surveys and Questionnaires 22 Erlotinib Hydrochloride 19 Nivolumab 18 Immunohistochemistry 16 Gefitinib 16 Drug Therapy 16 Gemcitabine 14 Pemetrexed 13 Gene Expression Profiling 13 durvalumab 12 Chemotherapy, Adjuvant 12 Radiation 11 Filgrastim 11 Bevacizumab 11 Surgical Procedures, Operative 10 Polymerase Chain Reaction 10 Amifostine 10 Celecoxib 9 Capecitabine 9 Standard of Care 8 Neoadjuvant Therapy 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Head and Neck Neoplasms × Diagnostic Imaging × Clear all

NCT02478138 2024-04-15

SLN Mapping

University Health Network, Toronto

Phase NA Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡